IGF-1 LR3 vs NAD+: What Is the Difference?
A fragile folded protein against a coenzyme that is not a protein at all. Two of the most demanding items here, for opposite reasons.
In plain English
IGF-1 LR3 is a folded protein of eighty-three amino acids — a modified growth signal engineered so carrier proteins cannot capture and hold it.
NAD+ is a coenzyme built from nucleotides rather than amino acids, present in every living cell and central to the chemistry of energy metabolism.
The difference, without the jargon
Both punish careless handling, but for unrelated reasons. IGF-1 LR3 is a folded structure that can come undone, and once it does it cannot refold itself. It needs acidic liquid to dissolve, an additive to stop it sticking to the container, and single-use portions because freezing and thawing damages it permanently. Damage leaves no visible trace. NAD+ has no shape to lose but absorbs moisture from the air so eagerly that opening a cold vial condenses water onto the contents. It is destroyed by alkaline conditions and comes in 500 mg quantities because reactions consume it in bulk. The habits that protect one do almost nothing for the other.
Common questions
What is the difference between IGF-1 LR3 and NAD+?
IGF-1 LR3 is a folded protein studied as a growth signal. NAD+ is a coenzyme consumed directly by the chemical reactions of energy metabolism. Different chemical families with unrelated handling requirements.
Why does IGF-1 LR3 need acidic liquid?
It does not dissolve well at neutral acidity. The standard approach is dilute acetic acid or dilute hydrochloric acid first, then dilution into the working liquid. Undissolved material in plain water is expected chemistry, not a faulty vial.
What is the single most useful habit with NAD+?
Letting the sealed vial reach room temperature before opening it. The powder pulls moisture from the air, and opening it cold condenses water directly onto the contents.
Technical reference below
How they actually differ
Comparing the two: IGF-1 LR3 is recombinant 83-residue protein analogue of igf-1, while NAD+ is dinucleotide coenzyme — not a peptide — different molecular classes with different handling consequences; they call for different primary diluents (dilute acetic acid (0.1 m) or 10 mm hcl — required for initial dissolution versus sterile or bacteriostatic water); their leading degradation routes differ (denaturation and aggregation for IGF-1 LR3, alkaline hydrolysis for NAD+), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
IGF-1 LR3 — origin
IGF-1 LR3 is an engineered analogue carrying two changes to native IGF-1: an arginine substitution at position 3 and a 13-residue N-terminal extension. The Arg3 substitution is the functional one — it drastically reduces binding to IGF binding proteins, which normally sequester the great majority of circulating IGF-1. The result is a molecule that stays free rather than bound.
NAD+ — origin
NAD+ is not a peptide at all, and that single fact governs everything about how it is handled. It is a dinucleotide coenzyme — nicotinamide and adenine linked through a pyrophosphate bridge — present in every living cell and central to redox metabolism. It was first identified in 1906 by Arthur Harden as a small heat-stable factor required for yeast fermentation.
IGF-1 LR3 research themes
The Arg3 substitution reduces binding-protein affinity, which is the entire design rationale.
Widely used in cell-culture research as a growth-factor supplement.
Studied in muscle-biology research models.
The canonical downstream pathway examined in IGF-1 receptor research.
NAD+ research themes
Sirtuins consume NAD+ as a co-substrate, which links cellular NAD+ availability directly to their activity.
Its canonical role as the central redox carrier of cellular respiration.
PARP enzymes consume NAD+ during DNA damage response, a heavily studied competing demand.
A major driver of current research interest: measured NAD+ levels fall with age across tissues in animal models.
IGF-1 LR3 handling
- Dissolve in dilute acetic acid or dilute HCl FIRST; do not attempt direct dissolution in water or PBS.
- Add carrier protein (e.g. 0.1% BSA) for storage of dilute solutions to prevent adsorptive loss.
- Prepare single-use aliquots — freeze–thaw denaturation is irreversible.
- Do not vortex; agitation denatures folded proteins at the air–liquid interface.
NAD+ handling
- Allow the sealed vial to reach room temperature before opening — opening a cold vial of hygroscopic material condenses water directly onto it.
- Keep solutions at or below neutral pH; alkaline conditions destroy NAD+ quickly.
- Prepare fresh solutions where concentration accuracy is important rather than relying on stored stock.
- Protect from light at all stages.
Both third-party tested
Every Popular Peptides batch of IGF-1 LR3 and NAD+ is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
IGF-1 LR3 reference
Related comparisons
IGF-1 LR3 and NAD+ are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.